ECO 2026
12 - 15 May 2026
CagriSema Reduces Predicted Atherosclerotic Cardiovascular Disease Risk in Adults With Overweight or Obesity: The REDEFINE 1 Trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.